Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons

Naimi, Adel and Mohammed, Rebar N. and Raji, Ahmed and Chupradit, Supat and Valerievich Yumashev, Alexei and Suksatan, Wanich and Shalaby, Mohammed Nader and Thangavelu, Lakshmi and Kamrava, Siavash and Shomali, Navid and Sohrabi, Armin D. and Adili, Ali and Noroozi-Aghideh, Ali and Razeghian, Ehsan (2022) Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons. Cell communication and signaling.

Full text not available from this repository.
Item Type: Article
Subjects: R Medicine > R Medicine (General)
Depositing User: Saeed Shoja
Date Deposited: 30 Aug 2022 04:02
Last Modified: 30 Aug 2022 04:02
URI: http://eprints.medsab.ac.ir/id/eprint/2165

Actions (login required)

View Item View Item
Medsab is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.